Group One Trading’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-37,200
| Closed | -$82.2K | – | 8567 |
|
|
2023
Q2 | $82.2K | Buy |
37,200
+24,700
| +198% | +$51.2K | ﹤0.01% | 4807 |
|
|
2023
Q1 | $31.8K | Buy |
12,500
+3,800
| +44% | +$7.51K | ﹤0.01% | 5197 |
|
|
2022
Q4 | $16.3K | Sell |
8,700
-38,100
| -81% | -$95K | ﹤0.01% | 5732 |
|
|
2022
Q3 | $120K | Buy |
46,800
+39,000
| +500% | +$97K | ﹤0.01% | 4610 |
|
|
2022
Q2 | $15K | Buy |
+7,800
| New | +$17K | ﹤0.01% | 6537 |
|
|
2022
Q1 | – | Sell |
-700
| Closed | -$3K | – | 8974 |
|
|
2021
Q4 | $3K | Sell |
700
-5,400
| -89% | -$25.6K | ﹤0.01% | 7834 |
|
|
2021
Q3 | $30K | Sell |
6,100
-26,100
| -81% | -$144K | ﹤0.01% | 6925 |
|
|
2021
Q2 | $220K | Buy |
32,200
+14,100
| +78% | +$114K | ﹤0.01% | 5151 |
|
|
2021
Q1 | $128K | Buy |
18,100
+11,600
| +178% | +$83.5K | ﹤0.01% | 5432 |
|
|
2020
Q4 | $41K | Sell |
6,500
-133,400
| -95% | -$785K | ﹤0.01% | 5142 |
|
|
2020
Q3 | $757K | Buy |
139,900
+19,800
| +16% | +$98K | ﹤0.01% | 2453 |
|
|
2020
Q2 | $627K | Buy |
120,100
+1,600
| +1% | +$7.11K | ﹤0.01% | 2445 |
|
|
2020
Q1 | $373K | Buy |
118,500
+96,700
| +444% | +$357K | ﹤0.01% | 2259 |
|
|
2019
Q4 | $88K | Buy |
+21,800
| New | +$75.6K | ﹤0.01% | 3725 |
|
|
2019
Q3 | – | Sell |
-6,200
| Closed | -$25K | – | 5689 |
|
|
2019
Q2 | $25K | Sell |
6,200
-71,800
| -92% | -$341K | ﹤0.01% | 4082 |
|
|
2019
Q1 | $418K | Buy |
78,000
+48,000
| +160% | +$310K | ﹤0.01% | 2086 |
|
|
2018
Q4 | $154K | Buy |
30,000
+20,100
| +203% | +$153K | ﹤0.01% | 2879 |
|
|
2018
Q3 | $96K | Sell |
9,900
-22,700
| -70% | -$229K | ﹤0.01% | 3568 |
|
|
2018
Q2 | $333K | Buy |
32,600
+7,100
| +28% | +$80.3K | ﹤0.01% | 2638 |
|
|
2018
Q1 | $332K | Buy |
25,500
+18,100
| +245% | +$269K | ﹤0.01% | 2372 |
|
|
2017
Q4 | $132K | Sell |
7,400
-26,900
| -78% | -$561K | ﹤0.01% | 3192 |
|
|
2017
Q3 | $861K | Sell |
34,300
-8,100
| -19% | -$189K | 0.01% | 1668 |
|
|
2017
Q2 | $1.02M | Sell |
42,400
-2,500
| -6% | -$55.3K | 0.01% | 1440 |
|
|
2017
Q1 | $864K | Buy |
+44,900
| New | +$707K | 0.01% | 1443 |
|
|
2016
Q4 | – | Sell |
-20,200
| Closed | -$263K | – | 4948 |
|
|
2016
Q3 | $263K | Buy |
20,200
+400
| +2% | +$5.3K | ﹤0.01% | 2283 |
|
|
2016
Q2 | $275K | Buy |
+19,800
| New | +$291K | ﹤0.01% | 2185 |
|
|
2015
Q1 | – | Sell |
-1,000
| Closed | -$39K | – | 5309 |
|
|
2014
Q4 | $39K | Buy |
1,000
+250
| +33% | +$5.97K | ﹤0.01% | 3537 |
|
|
2014
Q3 | $18K | Sell |
750
-8
| -1% | -$209 | ﹤0.01% | 4175 |
|
|
2014
Q2 | $18K | Buy |
758
+308
| +68% | +$10K | ﹤0.01% | 4237 |
|
|
2014
Q1 | $17K | Sell |
450
-142
| -24% | -$5.61K | ﹤0.01% | 4346 |
|
|
2013
Q4 | $24K | Buy |
592
+34
| +6% | +$1.44K | ﹤0.01% | 4158 |
|
|
2013
Q3 | $21K | Buy |
558
+66
| +13% | +$2.36K | ﹤0.01% | 4152 |
|
|
2013
Q2 | $18K | Buy |
+492
| New | +$21.1K | ﹤0.01% | 4139 |
|
Group One Trading's PRTK Position: Q2 2023 in Review
Group One Trading sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2023, closing a stake of 33,812 shares — an estimated $70.1K sold.
Group One Trading first reported a position in PRTK in Q2 2013 and held it in 21 quarters. The position peaked at $882K in Q4 2020. 66 funds tracked by Wall St. Rank hold PRTK as of Q2 2023.
- Group One Trading reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
- Group One Trading sold 33,812 Paratek Pharmaceuticals, Inc. shares in Q2 2023, an estimated $70.1K.
- Group One Trading first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 21 quarters.
- Group One Trading's Paratek Pharmaceuticals, Inc. position peaked at $882K in Q4 2020.
- 66 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2023.
Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.